2.3 Liquid and Semisolid Dosage Forms, Dispersions, and Topical Delivery

Monophasic Liquid Dosage Forms and Cosolvency

Monophasic liquid dosage forms represent true homogeneous molecular dispersions containing one or more chemical components dissolved in a single liquid phase. They provide rapid absorption, dosing flexibility for pediatric and geriatric patients, and immediate bioavailability.

Syrups, Elixirs, and Liquid Vehicles

• Syrups: Concentrated aqueous solutions of sucrose or other sugars.
  • USP Syrup (Simple Syrup) contains $85%$ w/v (or $65%$ w/w) sucrose in purified water, with a specific gravity of $1.313$. At this high osmotic concentration, the water activity ($a_w$) is depressed below $0.85$, preventing microbial proliferation without added chemical preservatives. Dilution of simple syrup requires adding antimicrobial preservatives (e.g., sodium benzoate, methylparaben).
  • Diabetic Syrups: Formulated with non-glycemic cellulose polymers (e.g., hydroxyethylcellulose, sodium carboxymethylcellulose) and artificial sweeteners (e.g., sucralose, saccharin sodium).
• Elixirs: Clear, sweetened, flavored hydroalcoholic solutions intended for oral use.
  • Ethanol Concentration: Varies from $5%$ to $40%$ v/v. Ethanol functions as a vital cosolvent to maintain poorly water-soluble organic compounds in solution.
  • Preservation: Formulations containing $> 15%$ to $20%$ ethanol are self-preserving against bacterial and fungal growth.
  • Clinical Cautions: Alcohol-containing elixirs must be avoided in pediatric populations and patients taking medications that induce disulfiram-like reactions (e.g., metronidazole, sulfonylureas) or severe central nervous system depression.
• Cosolvent Systems: Blending water with water-miscible organic solvents (e.g., propylene glycol, glycerin, polyethylene glycol 400) lowers the dielectric constant of the solvent blend, increasing the solubility of non-polar drug molecules by several orders of magnitude.

---

Coarse Dispersions: Pharmaceutical Suspensions

A suspension is a coarse two-phase dispersion in which insoluble solid drug particles (dispersed phase, typically $> 0.5\ \mu\text{m}$) are homogeneously distributed throughout a liquid vehicle (continuous phase).

Thermodynamic Instability and Stokes' Law

Suspensions are inherently thermodynamically unstable because milling particles into fine powders dramatically increases interfacial surface area ($\Delta A$), creating positive interfacial free energy ($\Delta G = \gamma_{SL} \cdot \Delta A$, where $\gamma_{SL}$ is solid-liquid interfacial tension). The system naturally minimizes free energy by particle agglomeration.

Particle sedimentation velocity under gravity is described by Stokes' Law:

$v = \frac{d^2 \cdot (\rho_p - \rho_m) \cdot g}{18 \cdot \eta}$

Where:

• $v$ is the sedimentation velocity ($\text{cm}/\text{s}$).
• $d$ is the particle diameter ($\text{cm}$).
• $\rho_p$ and $\rho_m$ are the densities of the solid particle and liquid medium ($\text{g}/\text{cm}^3$).
• $g$ is the gravitational acceleration constant ($980\text{ cm}/\text{s}^2$).
• $\eta$ is the dynamic viscosity of the medium ($\text{Poise}$ or $\text{Pa}\cdot\text{s}$).

Formulation Interventions to Retard Sedimentation:

1. Micronization: Because $d$ is squared, halving the particle diameter reduces sedimentation rate by a factor of 4.
2. Viscosity Enhancement: Suspending agents (e.g., xanthan gum, sodium carboxymethylcellulose, carbomers) increase $\eta$. Ideal suspending agents exhibit pseudoplastic (shear-thinning) and thixotropic rheology: high viscosity at rest to prevent settling on the shelf, but low viscosity upon shaking to facilitate pouring.

Flocculated vs. Deflocculated Suspensions

Suspension Stability Strategy:
  Deflocculated Particles --> Slow settling, BUT forms a cement-like, irreversible CAKE.
  Flocculated Particles   --> Fast settling, BUT easily REDISPERSED upon gentle shaking! (Preferred)

---

Emulsions and the HLB System

An emulsion is a thermodynamically unstable dispersion of two immiscible liquid phases (typically oil and water) stabilized by an amphiphilic emulsifying agent (surfactant).

Emulsion Types and Identification Tests

• Oil-in-Water (O/W): Oil droplets dispersed in continuous water phase. Washable with water, non-greasy, suitable for oral administration and cosmetically elegant creams.
• Water-in-Oil (W/O): Water droplets dispersed in continuous oil phase. Emollient, occlusive, non-water-washable, protective.
• Identification Tests:
  • Dilution Test: An emulsion can only be diluted with its continuous phase (O/W dilutes freely with water; W/O separates).
  • Conductivity Test: O/W emulsions conduct electric current due to dissolved aqueous electrolytes; W/O emulsions do not conduct.
  • Dye Solubility: Water-soluble dyes (e.g., amaranth) color O/W emulsions; oil-soluble dyes (e.g., Sudan III) color W/O systems.

The Hydrophilic-Lipophilic Balance (HLB) System

The Griffin HLB scale ranges from $1$ to $20$, categorizing surfactants by their relative hydrophilic versus lipophilic nature:

• HLB $3\text{ to }6$ (Lipophilic): Favors Water-in-Oil (W/O) emulsions (e.g., Sorbitan monooleate / Span 80, HLB $4.3$).
• HLB $8\text{ to }16$ (Hydrophilic): Favors Oil-in-Water (O/W) emulsions (e.g., Polysorbate 80 / Tween 80, HLB $15.0$).

HLB Calculation for Surfactant Blends:

$\text{HLB}_{\text{blend}} = (f_A \cdot \text{HLB}_A) + (f_B \cdot \text{HLB}_B)$

Where $f_A$ and $f_B$ are the weight fractions of surfactants A and B ($f_A + f_B = 1.0$).

Physical Instability Pathways in Emulsions

1. Creaming / Sedimentation: Upward movement of oil droplets (lower density) or downward settling of water droplets. Reversible upon shaking.
2. Flocculation: Reversible aggregation of droplets without rupture of the interfacial surfactant film.
3. Coalescence: Irreversible fusion of smaller droplets into larger droplets due to interfacial film breakdown.
4. Breaking (Cracking): Complete, irreversible phase separation into distinct bulk oil and water layers. Re-shaking cannot restore the emulsion.
5. Phase Inversion: Transition of an O/W emulsion to a W/O emulsion (or vice versa), triggered by temperature changes or addition of divalent electrolytes (e.g., adding $\text{Ca}^{2+}$ converts a sodium soap O/W emulsion to a calcium soap W/O emulsion).

---

Semisolid Dosage Forms and Topical/Transdermal Delivery

Semisolid preparations are applied to the skin or mucous membranes for local therapeutic action or systemic transdermal absorption.

USP Ointment Base Classification

Percutaneous Absorption Kinetics and Transdermal Drug Delivery

The primary barrier to percutaneous absorption is the stratum corneum (the outermost keratinized epidermal layer structured as "bricks and mortar").

Fick's First Law of Transdermal Diffusion:

$J = \frac{D \cdot K \cdot \Delta C}{h}$

Where:

• $J$ is the steady-state transdermal drug flux ($\text{mass}/(\text{area}\cdot\text{time})$).
• $D$ is the diffusion coefficient of the drug within the stratum corneum.
• $K$ is the stratum corneum / vehicle partition coefficient.
• $\Delta C$ is the drug concentration gradient across the skin.
• $h$ is the barrier thickness of the stratum corneum.

Transdermal Patch Architectures and Clinical Safety

• Reservoir Patches: Drug is contained within a liquid reservoir separated from the skin by a rate-controlling polymeric membrane. Critical Safety Rule: Reservoir patches must NEVER be cut, as cutting ruptures the rate-controlling membrane, causing catastrophic dose dumping and fatal toxicity.
• Matrix / Drug-in-Adhesive Patches: Drug is homogeneously dissolved or suspended directly within the adhesive matrix layer. The release rate is governed by the matrix polymer and skin barrier.
• Heat and Transdermal Toxicity: Elevated body temperature (fever) or external heat sources (electric heating pads, saunas, hot tubs) induce cutaneous vasodilation, elevate skin temperature, and increase the diffusion coefficient $D$. This causes massive surges in drug flux (e.g., transdermal fentanyl flux can increase by $> 100-300%$, precipitating fatal respiratory arrest).
• MRI Safety: Patches with metallic backings (e.g., aluminum backing in certain clonidine, fentanyl, or scopolamine patches) can cause severe local skin burns during magnetic resonance imaging (MRI) and must be removed prior to scanning.